MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.76 -0.12 (-6.82%)	0.01 (0.61%)	0.01 (0.61%)	-0.12 (-6.82%)	---	---	-0.12 (-6.82%)	-0.12 (-6.82%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -18.2222
Diluted P/E:: -18.2222
RSI(14) 1m:: 61.54
VWAP:: 1.65
RVol:: 0.0874

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.12 -0.08 (-3.75%)	Oct 16 11:10
10m	Price decrease 10m	2.12 -0.08 (-3.75%)	Oct 16 11:10
1m	Price decrease 1m	2.19 -0.02 (-1.1%)	Oct 16 11:09
1m	Price increase 1m	2.22 +0.06 (+2.55%)	Oct 16 11:08
10m	Price increase 10m	2.17 +0.15 (+7.4%)	Oct 16 11:07